HomeAMRN • NASDAQ
add
Amarin Corporation PLC
Nakaraang pagsara
$14.97
Sakop ng araw
$14.83 - $15.01
Sakop ng taon
$7.08 - $17.46
Market cap
310.45M USD
Average na Volume
60.44K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 72.74M | 7.78% |
Gastos sa pagpapatakbo | 43.59M | 0.68% |
Net na kita | -14.14M | -1,028.98% |
Net profit margin | -19.44 | -960.18% |
Kita sa bawat share | 0.87 | 335.00% |
EBITDA | 7.50M | 3,065.82% |
Aktuwal na % ng binabayarang buwis | -5.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 298.70M | -2.60% |
Kabuuang asset | 670.13M | -16.22% |
Kabuuang sagutin | 205.20M | -17.25% |
Kabuuang equity | 464.92M | — |
Natitirang share | 20.68M | — |
Presyo para makapag-book | 0.67 | — |
Return on assets | 2.55% | — |
Return on capital | 3.53% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -14.14M | -1,028.98% |
Cash mula sa mga operasyon | 16.61M | 704.07% |
Cash mula sa pag-invest | 12.41M | 164.32% |
Cash mula sa financing | -663.00K | -2,050.00% |
Net change in cash | 28.35M | 1,331.97% |
Malayang cash flow | 15.31M | 453.02% |
Tungkol
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Itinatag
Mar 1, 1989
Headquarters
Website
Mga Empleyado
275
